跳至主要内容
临床试验/NCT03358602
NCT03358602尚未招募不适用

Radiotherapy Versus Elective Neck Dissection for Management of Cervical Nodes in Clinical T1/2N0 Supraglottic Squamous Cell Carcinoma

Tianjin Medical University Cancer Institute and Hospital1 个研究点 分布在 1 个国家目标入组 158 人开始时间: 2017年12月20日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
158
试验地点
1
主要终点
Neck control rates

研究概览

简要总结

Supraglottic cancer is a main type of laryngeal carcinoma, which is one of the most common head and neck tumors. Cervical nodal metastasis is an important prognostic factor in supraglottic cancer. Current management, following the US National Comprehensive Cancer Network guidelines for T1-2, N0 supraglottic cancer (NCCN 2017), is either definitive radiotherapy or primary surgery with or without neck dissection. The optimal neck treatments strategy remains unclear in clinical settings owing to the limitation of a small number of retrospective studies and a lack of prospective trials. The investigators conducted a prospective, randomised trial to compare radiotherapy with neck dissection.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Ability to understand and the willingness to sign a written informed consent document
  • Age≥ 18 and≤ 75 years
  • Histological/ cytological/ Imaging examination proven supraglottic squamous-cell carcinoma in preoperative assessment
  • Cervical node negative according to the imaging characteristics and the physical examination
  • Normal bone marrow reserve function and normal liver, kidney function
  • Expected survival period≥ 12 months

排除标准

  • Inability to provide an informed consent
  • Proved distant metastasis
  • Clinical stage 3-4
  • The patient has received prior surgery or radiotherapy (except for biopsy )
  • The patient has received chemotherapy(including targeted therapies) or immunotherapy
  • Prior malignancy within the previous 5 years
  • Severe mental disorders
  • Pregnant or lactating women
  • Other disease requiring simultaneous surgery or radiotherapy
  • Researchers believe that the situation is unsuitable for participation in the group

结局指标

主要结局

Neck control rates

时间窗: 2 years

The percentage of patients without cervical lymph node metastasis

次要结局

  • Treatment cost(4 weeks)
  • Overall survival(5 years)
  • Quality of life (EORTC QLQ-C30)(1 year)
  • Disease-free survival(5 years)
  • Quality of life (EORTC QLQ-HN35)(1 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Radiotherapy vs Neck Dissection for Clinical T1/2N0... | 临床试验